NICE, FDA Boost Oncology Drug Options

Drug approvals expand the armamentarium for lung cancer, gastric cancer and myeloproliferative diseases

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.